Progress and controversy surrounding vaccines against Lyme disease

References

• Steere AC. LD. N Engl. J. Med. 345, 115–125 (2001).
   Google Scholar
• ••An excellent, authoritative general review of LD.
   Google Scholar
• Burgdorfer W Barbour AG, Hayes HayesS, Benach JL, Grunwaldt Davis, E. JP. LD-a tick-borne spirochetosis? Science 216, 1317–1319 (1982).
   PubMed Web of Science ®Google Scholar
• Benach JL, Bosler EM, Hanrahan JP et al. Spirochetes isolated from the blood of two patients with LD. N Engl. J. Med 308, 740–742 (1983).
   PubMed Web of Science ®Google Scholar
• Wang G, van Darn AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological and clinical implications. Gin. Mcrobiol Rev 12, 633–653 (1999).
   PubMed Web of Science ®Google Scholar
• Strle E Lyme borreliosis in Slovenia. Zentralbl. Bakteriol. 289, 643–652 (1999).
   Google Scholar
• James AM, Liveris D, Wormser GP, Schwartz I, Montecalvo MA, Johnson BJ. Borrelia lonestari infection after a bite by an Amblyomma americanumtick. J. Infect. Dis. 183, 1810–1814 (2001).
   PubMed Web of Science ®Google Scholar
• Anderson JF, Magnarelli LA. A tick-associated disease originally described in Europe but named after a town in Connecticut. Am. Entomol 217–227 (1994).
   Google Scholar
• Steere AC, Malawista SE, Snydman DR etal. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20, 7–17 (1977).
   PubMed Web of Science ®Google Scholar
• Scrimenti RJ. Erythema chronicum migrans. Arch. Dennatol 102, 104–105 (1970).
   Google Scholar
• Schmid GP. The global distribution of LD. Rev Infect DA 7,41–50 (1985).
   PubMedGoogle Scholar
• Summary of Notifiable Diseases — United States, 2001. Morbid Mortal. Wkly Rep. 50(53), 1–108 (2003).
   Google Scholar
• Coyle BS, Strickland GT, Liang YY, Pena C, McCarter R, Israel E. The public health impact of LD in Maryland. J. Infect. DA. 173, 1260–1262 (1996).
   PubMed Web of Science ®Google Scholar
• Fish D. Environmental risk and prevention of LD. ATIZ J. Med 98, 2S-8S (1995).
   Google Scholar
• Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the LDspirochete, Borrelia burgdorferi. j Lied. Dis. 167, 1074–1081 (1993).
   Google Scholar
• Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis — randomised comparison of ceftriaxone and penicillin. Lancetl, 1191–1194 (1988).
   Google Scholar
• Duray PH, Johnson RC. The histopathology of experimentally infected hamsters with the LD spirochete, Borrelia burgdorferi. Proc. Soc. Exp. Biol. Med. 181, 263–269 (1986).
   PubMed Web of Science ®Google Scholar
• Hejka A, Schmitz JL, England DM, Callister SM, Schell RE Histopathology of Lyme arthritis in LSH hamsters. Am. J. Pathol 134, 1113–1123 (1989).
   PubMed Web of Science ®Google Scholar
• Shadick NA, Phillips CB, Lcgigian EL et al The long-term clinical outcomes of LD. A population- based retrospective cohort study. Ann Intern Med 121,560–567 (1994).
   Google Scholar
• Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of LD. N Engl. J. Med. 345, 85–92 (2001).
   PubMed Web of Science ®Google Scholar
• Steere AC, Dwyer E, Winchester R Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl Med. 323, 219–223 (1990). Erratum appears In N Engl j Med. 324(2),129 (1991).
   Google Scholar
• Kalish RA, Leong JM, Steere AC. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61, 2774–2779 (1993).
   Google Scholar
• Kalish RA, Leong JM, Steere AC. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Bonelia burgdarferi in LD. Infect Immun. 63, 2228–2235 (1995).
   Google Scholar
• Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of LD. J. Infect. Dis. 167, 392–400 (1993).
   PubMed Web of Science ®Google Scholar
• Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early LD. j Gin. Mcrobiol 31, 3090–3095 (1993).
   Google Scholar
• Fung BP, McHugh GL, Leong JM, Steere AC. Humoral immune response to outer surface protein C of Borrelia burgdorferi in LD: role of the immunoglobulin M response in the serodiagnosis of early infection. /fiat /n/nun 62, 3213–3221 (1994).
   Google Scholar
• Craft JE, Fischer DK, Shimamoto GT, Steere AC. Antigens of Bondia burgdorferi recognized during LD. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J. Gun. Invest. 78, 934–939 (1986).
   Google Scholar
• Pikrig E, Huguenel ED, Berland R, Rahn DVV, Hardin JA, Flavell RA. Serologic diagnosis of LD using recombinant outer surface proteins A and B and flagellin. Infect. Dis. 165, 1127–1132 (1992).
   Web of Science ®Google Scholar
• Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10–20 years after active LD. Clin. Infect. Dis. 33, 780–785 (2001).
   Google Scholar
• Barbour AG, Tessier SL, Todd WJ. LD spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect. Immun. 41, 795–804 (1983).
   Google Scholar
• Will G, Jauris-Heipke S, Schwab E eta] Sequence analysis of OspA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia gariniispecies. Med. Mcrobiol Immunol (1r1) 184, 73–80 (1995).
   Google Scholar
• Wilske B, Preac-Mursic V, Gobel UB eta] An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. Gin. Mcrobiol. 31, 340–350 (1993).
   Web of Science ®Google Scholar
• Sadziene A, Jonsson M, Bergstrom S, Bright RK, Kennedy RC, Barbour AG. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect. Immun. 62, 2037–2045 (1994).
   PubMed Web of Science ®Google Scholar
• Shoberg RJ, Jonsson M, Sadziene A, Bergstrom S, Thomas DD. Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Bondia spp. causing LD. j Clin. Mcmbiol 32, 489–500 (1994).
   Google Scholar
• Jauris-Heipke S, Liegl G, Preac-Mursic V eta] Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferisensu lato: relationship to OspA genotype and evidence of lateral gene exchange of OspC. j Gun. Mcrobiol. 33, 1860–1866 (1995).
   Web of Science ®Google Scholar
• Wilske B, Jauris-Heipke S, Lobentanzer R eta] Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.Mcmbiol 33, 103–109(1995).
   Google Scholar
• Pal U, Montgomery RR, Lusitani D, Voet P et al. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody. J. Immunol 166, 7398–7403 (2001).
   PubMed Web of Science ®Google Scholar
• Steere AC, Grodzicki PL, Komblatt AN eta] The spirochetal etiology of LD. N Engl. Med. 308, 733–740 (1983).
   PubMed Web of Science ®Google Scholar
• Shadick NA, Phillips CB, Sangha 0 et al Musculoskeletal and neurologic outcomes in patients with previously treated LD. Ann. Intern. Med. 131,919-926 (1999).
   Google Scholar
• Kalish RA, Kaplan RE Taylor E, Jones- Woodward L, Workman K, Steere AC. Evaluation of study patients with LD, 10-20-year follow-up. J. Infect. Dis. 183, 453–460 (2001).
   Google Scholar
• Hanrahan JP, Benach JL, Coleman JL etal. Incidence and cumulative frequency of endemic LD in a community. J. Infect. Dis.150,489–496 (1984).
   Google Scholar
• Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of the clinical and epidemiological features of LD in a defined population. J. Infect. Dis. 154, 295–300 (1986).
   Google Scholar
• Guy EC, Bateman DE, Martyn CN, Heckels JE, Lawton NE LD: prevalence and clinical importance of Borrelia burgdorferispecific IgG in forestry workers. Lancetl, 484–486 (1989).
   Google Scholar
• Gustafson R, Svenungsson B, Gardulf A, Stiernstedt G, Forsgren M. Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population. Scand Infect. Dis. 22,297–306 (1990).
   Google Scholar
• Fahrer H, van der Linden SM, Sauvain MJ, Gem L, Zhioua E, Aeschlimann A. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J. Infect. Dir. 163, 305–310 (1991).
   PubMed Web of Science ®Google Scholar
• Feder HM, Jr., Gerber MA, Cartter ML, Sikand V, Krause PJ. Prospective assessment of LD in a school-aged population in Connecticut. J. Infect. Dis. 171, 1371–1374 (1995).
   PubMed Web of Science ®Google Scholar
• Curran KL, Fish D, Piesman J. Reduction of nymphal Ixodes dammini Acari: Ixodidae in a residential suburban landscape by area application of insecticides.j Med Entomol. 30,107–113 (1993).
   PubMed Web of Science ®Google Scholar
• Deblinger RD, Wilson ML, Rimmer Spielman A. Reduced abundance of immature Ixodes dammini Acari: Ixodidae) following incremental removal of deer. J. Med. Entomol 30,144–150 (1993).
   PubMed Web of Science ®Google Scholar
• Shadick NA, Daltroy LH, Phillips CB, Liang US, Liang MH. Determinants of tick-avoidance behaviors in an endemic area for LD. Am. J. Prey Med 13,265–270 (1997).
   Google Scholar
• Anonymous. LD — United States, 1994. JA/V/A 274,111 (1995).
   Google Scholar
• Barbour AG, Fish D. The biological and social phenomenon of LD. Science 260, 1610–1616 (1993).
   PubMed Web of Science ®Google Scholar
• Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative LD. Dissociation of specific T-and B-lymphocyte responses to Bortelia burgdorferi. N Engl. Med. 319, 1441–1446 (1988).
   Google Scholar
• Preac-Mursic V, Weber K, Pfister HW etal. Survival of Bond/a burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17,355–359 (1989).
   Google Scholar
• Johnson RC, Kodner C, Russell M. Passive immunization of hamsters against experimental infection with the LD spirochete. Infect. Immun. 53,713–714 (1986).
   PubMed Web of Science ®Google Scholar
• Schmitz JL, Schell RF, Hejka A, England DM, Konick L. Induction of Lyme arthritis in LSH hamsters. Infect. Immun. 56, 2336–2342 (1988).
   PubMed Web of Science ®Google Scholar
• Schaible UE, Kramer MD, Museteanu C, Zimmer G, Mossmann H, Simon MM. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. Exp. Med. 170,1427–1432 (1989).
   Google Scholar
• Fikrig E, Barthold SW Kantor FS, Flavell RA. Protection of mice against the LD agent by immunizing with recombinant OspA. Science 250,553–556 (1990).
   PubMed Web of Science ®Google Scholar
• Simon MM, Schaible UE, Kramer MD etal. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J. Infect. Dis. 164,123–132 (1991).
   Google Scholar
• Preac-Mursic V, Wilske B, Patsouris E eta]. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi Infection. Infection 20, 342–349 (1992).
   Google Scholar
• Philipp MT, Aydintug MK, Bohm RP Jr etal. Early and early disseminated phases of LD in the rhesus monkey: a model for infection in humans. Infect. Immun. 61, 3047–3059 (1993).
   Google Scholar
• Appel MJ, Allan S, Jacobson PH eta]. Experimental LD in dogs produces arthritis and persistent infection. J. Infect. Dir. 167, 651–664 (1993).
   PubMed Web of Science ®Google Scholar
• Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Nat! Acad. Li. USA 92,2909–2913 (1995).
   Google Scholar
• •Good study of Bb antigenic modulation during tick feeding.
   Google Scholar
• Schwan TG, Piesman J. Temporal changes in outer surface proteins A and C of the LD- associated spirochete, Bortelia burgdorferi, during the chain of infection in ticks and mice. J. Gin. Mcrobiol. 38, 382–388 (2000).
   PubMed Web of Science ®Google Scholar
• Edelman R. Perspective on the development of vaccines against LD. Vaccine 9,531–532 (1991).
   PubMed Web of Science ®Google Scholar
• Weber K, Schierz G, Wilske B etal. Reinfection in erythema migrans disease. Infection 14,32–35 (1986).
   Google Scholar
• Pfister HW, Neubert U, Wilske B, Preac- Mursic V, Einhaupl KM, Borasio GD. Reinfection with Borrelia burgdorferi Lancet2, 984–985 (1986).
   PubMed Web of Science ®Google Scholar
• Nowakowski J, Schwartz I, Nadelman RB, Livers D, Aguero-Rosenfeld M, Wormser GP. Culture-confirmed infection and reinfection with Borrelia burgdorferi Ann. Intern. Med. 127,130–132 (1997).
   PubMed Web of Science ®Google Scholar
• Johnson RC, Kodner C, Russell M. Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect. Immun. 54,897–898 (1986).
   Google Scholar
• Schmitz JL, Schell RF, Hejka AG, England DM. Passive immunization prevents induction of Lyme arthritis in LSH hamsters. Infect. Immun 58,144-148 (1990)Erratum appears in Infect. Immun. 61(4,791 (1993).
   Google Scholar
• Johnson RC, Kodner C, Russell M, Duray PH. Experimental infection of the hamster with Borrelia burgdorferi. Ann. NY Acad.Li. 539,258–263, (1988).
   PubMed Web of Science ®Google Scholar
• Simon MM, Schaible UE, Wallich R, Kramer MD. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against LD. Immunol Today12,11–16 (1991).
   PubMedGoogle Scholar
• Piesman J, Maupin GO, Campos EG, Happ CM. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, with description of a needle aspiration isolation method. J. Infect. Dis. 163,895–897 (1991).
   PubMed Web of Science ®Google Scholar
• Piesman J. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. Infect. Dis. 167,1082–1085 (1993).
   Web of Science ®Google Scholar
• des VF, Piesman Heffernan, J. R, Schulze SchulzeT, Stafford KC, III, Fish D. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapular's nymphs. J. Infect. Dis. 183, 773–778 (2001).
   Google Scholar
• Kahl 0, Janetzki-Mittmann C, Gray JS, Jonas R, Stein J, de Boer R. Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal. Zentralbl Bakteriol. 287,41-52 (1998).
   Google Scholar
• ••.
   Google Scholar
• Burkot TR, Piesman J, Wirtz RA. Quantitation of the Borrelia burgdorferi outer surface protein A in Ixodes scapularis: fluctuations during the tick life cycle, doubling times and loss while feeding. J. Infect. Dis. 170,883-889 (1994).
   Google Scholar
• Shih CM, Spielman A, Telford SR 3rd. Short report: mode of action of protective immunity to LD spirochetes. Am. J. Trop. Med I-bg. 52,72-74 (1995).
   Google Scholar
• Fikrig E, Telford SR 3rd, Barthold SW Kantor FS, Spielman A, Flavell RA. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Pmc. Nat/Acad. Sri. USA 89, 5418–5421 (1992).
   Google Scholar
• ••Important study of the mechanism ofimmunity to tick-transmitted Bb.
   Google Scholar
• Nguyen TP, Lam TT Barthold SW Telford SR 3rd, Flavell RA, Fikrig E. Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect. Immun. 62, 2079–2084 (1994).
   Google Scholar
• Telford SR 3rd, Kantor FS, Lobet Y, Barthold SW Spielman A, Flavell RA, Fikrig E. Efficacy of human LD vaccine formulations in a mouse model. J. Infect. Dis. 171,1368-1370 (1995).
   Google Scholar
• Fikrig E, Telford SR 3rd, Wallich R eta]. Vaccination against LD caused by diverse Borrelia burgdorferi. J. Exp. Med 181, 215–221 (1995).
   Google Scholar
• Piesman J, Mather TN, Sinsky RJ, Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J. Gun. Mcrobiol 25,557–558 (1987).
   PubMed Web of Science ®Google Scholar
• de Silva AM, Telford SR 3rd, Brunet LR, Barthold SW Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking LD vaccine. J. Exp. Med 183,271–275 (1996).
   Google Scholar
• •Documentation supporting the transmission-blocking mechanism of OspA immunity.
   Google Scholar
• Gilmore RD Jr, Piesman J. Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice. Infect. Immun. 68,411–414 (2000).
   PubMed Web of Science ®Google Scholar
• Zhong W Stehle Museteanu, T. C eta]. Therapeutic passive vaccination against chronic LD in mice. Proc. Natl Arad Sc]. USA 94,12533–12538 (1997).
   Google Scholar
• Piesman J, Dolan MC, Happ CM etal. Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice. Infect. Immun. 65, 4043–4047 (1997).
   Google Scholar
• Lovrich SD, Canister SM, Lim LC, DuChateau BK, Schell RF. Seroprotective groups of Lyme Borreliosis spirochetes from North America and Europe. J. Infect. Dis. 170,115–121 (1995).
   Google Scholar
• Schaible UE, Wallich R, Kramer MD etal. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype. Vaccinell, 1049–1054 (1993).
   Google Scholar
• Hanson MS, Cassatt DR, Guo BP eta] Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect. Immun. 66,2143–2153 (1998).
   PubMed Web of Science ®Google Scholar
• Probert WS, Crawford M, Cadiz RB, LeFebvre RB. Immunization with outer surface protein (Osp) A but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J. Infect. Dis. 175, 400–405 (1997).
   PubMed Web of Science ®Google Scholar
• Telford SR 3rd, Fikrig E, Barthold SW Brunet LR, Spielman A, Flavell RA. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. J. Exp. Med 178, 755–758 (1993).
   Google Scholar
• Golde 'NT, Burkot TR, Piesman J et al. The LD vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Vaccine 13,435-441 (1995).
   Google Scholar
• Barthold SW Specificity of infection- induced immunity among Borrelia burgdorferi sensu lato species. Infect. Immun. 67,36–42 (1999).
   Google Scholar
• Gem L, Hu CM, Voet P, Hauser P, Lobet Y. Immunization with a polyvalent OspA vaccine protects mice against Ixodes rkinus tick bites infected by Borrelia burgdorferi ss, Borirliagarinli and Borrelia afzelii Vaccine 15,1551–1557 (1997).
   Google Scholar
• Lovrich SD, Canister SM, Schmitz JL, Alder JD, Schell RF. Borreliacidal activity of sera from hamsters infected with the LD spirochete. Infect. Immun. 59,2522–2528 (1991).
   PubMed Web of Science ®Google Scholar
• Sadziene A, Thompson PA, Barbour AG. In vitm inhibition of Borrelia burgdorferi growth by antibodies. J. Infect. Dis. 167, 165–172 (1993).
   Google Scholar
• •Thorough laboratory investigation of direct killing of Bb by antibodies.
   Google Scholar
• Coleman JL, Rogers RC, Benach JL. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Infect. Immun. 60,3098–3104 (1992).
   Google Scholar
• Schmitz JL, Lovrich SD, Canister SM, Schell RF. Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi. Infect. Immun. 59,3815–3818 (1991).
   PubMed Web of Science ®Google Scholar
• Scriba M, Ebrahim JS, Schlott T, Eiffert H The 39-kilodalton protein of Borrelia burgdorferi a target for bactericidal human monoclonal antibodies. Infect. Immun. 61, 4523–4526 (1993).
   Google Scholar
• Canister SM, Schell RF, Case KL, Lovrich SD, Day SP. Characterization of the borreliacidal antibody response to Borrelia burgdorferiin humans: a serodiagnostic test Infect. Dis. 167,158–164 (1993).
   Google Scholar
• Keller D, Koster FT, Marks DH, Hosbach P, Erdile LF, Mays JP. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. JA/VIA 271, 1764–1768 (1994).
   Google Scholar
• Padilla ML, Callister SM, Schell RF eta]. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine. J. Infect. Dis. 174,739–746 (1996).
   Google Scholar
• Benach JL, Fleit HB, Habicht GS, Coleman JL, Bosler EM, Lane BR Interactions of phagocytes with the LD spirochete: role of the Fc receptor. J. Infect. Dis. 150,497–507 (1984).
   PubMed Web of Science ®Google Scholar
• Modolell M, Schaible UE, Rittig M, Simon MM. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol Lett. 40,139–146 (1994).
   PubMed Web of Science ®Google Scholar
• Lengl-Janssen B, Strauss AF, Steere AC, Kamradt T The T-helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. 'Exp. Med. 180,2069–2078 (1994).
   PubMed Web of Science ®Google Scholar
• Keane-Myers A, Nickell SP. T-cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol 154,1770–1776 (1995).
   Google Scholar
• Schaible UE, Kramer MD, Eichmann K, Modolell M, Museteanu C, Simon MM. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis insevere combined immunodeficiency (scid) mice. Proc. Natl Acad Sc]. USA 87, 3768–3772 (1990).
   PubMed Web of Science ®Google Scholar
• Sears JE, Fikrig E, Nakagawa TY eta] Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of LD. j Immunol 147, 1995–2000 (1991).
   PubMed Web of Science ®Google Scholar
• Van Hoecke C, Comberbach M, De Grave D et al Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults. Vaccine14, 1620–1626 (1996).
   PubMed Web of Science ®Google Scholar
• Van Hoecke C, Fu D, De Grave D, Voet P, Lebacq E. Clinical and immunological assessment of a candidate LD vaccine in healthy adults: antibody persistence and effect of a booster dose at month 12. Vaccine 16, 1688–1692 (1998).
   Google Scholar
• Probert WS, LeFebvre RB. Protection of C3H/HeN mice from challenge with Borrelia burgdorferithrough active immunization with OspA, OspB, or OspC but not with OspD or the 83-kilodalton antigen. Infect. Immun 62, 1920-1926 (1994).
   Google Scholar
• Rousselle JC, Canister SM, Schell RF eta]. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi j Infect. Dis. 178, 733–741 (1998).
   Google Scholar
• Zeidner N, Dreitz M, Belasco D, Fish D. Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-a, interleukin-2 and interferon-1. J. Infect. Dis. 173,187-95 (1996).
   Google Scholar
• Barthold SW de Souza M. Exacerbation of Lyme arthritis in beige mice. J. Infect. Dis. 172, 778–784 (1995).
   Google Scholar
• Fikrig E, Barthold SW Kantor FS, Flavell RA. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J. Infect. Dir. 164, 1224–1227 (1991).
   PubMed Web of Science ®Google Scholar
• Fikrig E, Barthold SW Persing DH, Sun X, Kantor Kantor F, Flavell RA. Borrelia burgdorferi strain 25015, characterization of outer surface protein A and vaccination against infection. Immund 148, 2256–2260 (1992).
   PubMed Web of Science ®Google Scholar
• Fikrig E, Barthold SW Kantor FS, Flavell RA. Long-term protection of mice from LD by vaccination with OspA. Infect. Immun. 60, 773–777 (1992).
   PubMed Web of Science ®Google Scholar
• Fikrig E, Barthold SW Marcantonio Deponte, N. K, Kantor Kantor F, Flavell RA. Roles of OspA, OspB and flagellin in protectiveimmunity to Lyme borreliosis in laboratory mice. Infect. Immun. 60, 657–661 (1992).
   PubMed Web of Science ®Google Scholar
• Erclile LF, Brandt MA, Warakomski DJ etal. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61, 81–90 (1993).
   Google Scholar
• Steere AC, Sikand VK, Meurice F eta]. Vaccination against LD with recombinant Borrelia burgdorferi Outer-surface lipoprotein A with adjuvant. N Engl. J. Med 339, 209–215 (1998).
   Google Scholar
• •Pivotal trial of human LD vaccine LYMErix.
   Google Scholar
• Sigal LH, Zahradnik JM, Lavin P etal. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent LD. N &ig1j Med. 339, 216–222 (1998).
   Google Scholar
• •Pivotal trial of human LD vaccine ImuLyme.
   Google Scholar
• Lissman BA, Bosler EM, Camay H, Ormiston BG, Benach JL. Spirochete-associated arthritis (LD) in a dog. jAm. Vet. Med. Assoc. 185, 219–220 (1984).
   PubMed Web of Science ®Google Scholar
• Levy SA, Magnarelli LA. Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. jAm. Vet. Med. Assoc. 200, 344–347 (1992).
   PubMed Web of Science ®Google Scholar
• Kazmierczak JJ, Sorhage FE. Current understanding of Borrelia burgdorferi infection, with emphasis on its prevention in dogs. Am. lit Med. Assoc. 203, 1524–1528 (1993).
   Web of Science ®Google Scholar
• Levy SA, Lissman BA, Ficke CM. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. jAm. Vet. Med. Assoc. 202, 1834–1838 (1993).
   Google Scholar
• Lim LC, England DM, DuChateau BK etal. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdolferi. Infect. Immun. 62, 2825–2833 (1994).
   Google Scholar
• Lim LC, England DM, DuChateau BK, Glowacki NJ, Schell RF. Borrelia burgdorferi-specific T-lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63, 1400–1408 (1995).
   Google Scholar
• Sigal LH, Tatum AH. LD patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology38, 1439–1442 (1988).
   PubMed Web of Science ®Google Scholar
• Aberer E, Brunner C, Suchanek G eta]. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human. Ann. Neurol 26, 732–737 (1989).
   Google Scholar
• Mensi N, Webb DR, Turck CVV, Peitz GA. Characterization of Borrelia burgdorferi proteins reactive with antibodies in synovial fluid of a patient with Lyme arthritis. Infect. Immun. 58, 2404–2407 (1990).
   PubMed Web of Science ®Google Scholar
• Sigal LH. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein. J. Infect. Dis. 167, 1372–1378 (1993).
   Google Scholar
• Ma J, Bulger PA, Dante S, Davis DR, Perini-Palmer B, Coughlin Kr. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by LD spirochetes. Infect. Dis. 171,909–915 (1995).
   Google Scholar
• Coughlin RI; Fish D, Mather TN, Ma J, Pavia C, Bulger P Protection of dogs from LD with a vaccine containing outer surface protein (Osp) A, OspB and the saponin adjuvant Q521. Infect. Dis. 171, 1049–1052 (1995).
   Google Scholar
• Ma J, Bulger PA, Davis DR etal. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi. Vaccine 12, 925–932 (1994).
   Google Scholar
• Philipp MT, Lobet Y, Bohm RP Jr eta] The outer surface protein A (OspA) vaccine against LD: efficacy in the rhesus monkey. Vaccine 15, 1872–1887 (1997).
   PubMed Web of Science ®Google Scholar
• Schoen RT, Reimann J, Fikrig E. Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous LD.J. Infect Dis. 172, 1324–1329 (1995).
   Google Scholar
• Van Hoecke C, Lebacq E, Beran J, Parenti D. Alternative vaccination schedules (0, 1 and 6 months versus 0, 1 and 12 months) for a recombinant OspA LD vaccine. Gin. Infect Dis. 28, 1260–1264 (1999).
   Google Scholar
• Schoen RI, Sikand VK, Caldwell MC etal. Safety and immunogenicity profile of a recombinant outer-surface protein A LD vaccine: clinical trial of a 3-dose schedule at 0, 1 and 2 months. Gun. Tiler. 22, 315–325 (2000).
   Google Scholar
• Feder HM Jr, Beran J, Van Hoecke C etal. Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against LD in children. J. Pediatr 135, 575–579 (1999).
   Google Scholar
• Beran J, De Qercq N, Dieussaert I, Van Hoecke C. Reactogenicity and immunogenicity of a LD vaccine in children 2–5 years old. Gun. Infect. Dis. 31, 1504–1507 (2000).
   Google Scholar
• Sikand VK, Halsey N, Krause PJ etal. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against LD in healthy children and adolescents: a randomized controlled trial. Pediatrics 108, 123–128 (2001).
   PubMed Web of Science ®Google Scholar
• Kurtenbach K, Dizij A, Voet P, Hauser P, Simon MM. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against LD spirochaetes associated with high levels of LA-2 equivalent antibodies. Vaccine 15, 1670–1674 (1997).
   Google Scholar
• Golde WT, Piesman J, Dolan MC eta] Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the LD spirochete, Borrelia burgdorferi. Infect. Immun. 65,882–889 (1997).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommendations for the use of LD vaccine. Morb. Mortal. Wkly Rep 48(RR-7), 1–25 (1999).
   Google Scholar
• Nadelman RB, Nowakowski J, Fish D eta] Prophylaxis with single-dose doxycycline for the prevention of LD after an Ixodes scapuladstickbite. N Engif Med. 345, 79–84 (2001).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Committee on Infectious Diseases. Prevention of LD. Pediatrics 105,142–147 (2000).
   PubMedGoogle Scholar
• Parenti DL, Gillet M, Sennewald E etal. Correlate of protection for LD (LD) using LYMErixTm, recombinant, adjuvanted Borrelia burgdorferi outer surface lipoprotein A (L-OspA) vaccine. Clin. Infect. Dis. 27,1053.1998.
   Google Scholar
• Rahn DW. Lyme vaccine: issues and controversies. Infect. Dis. Clin. N Am. 15, 171–187 (2001).
   PubMed Web of Science ®Google Scholar
• Meltzer MI, Dennis DT, Orloski KA. The cost effectiveness of vaccinating against LD. Emerg. Infect. Dis. 5,321–328 (1999).
   PubMed Web of Science ®Google Scholar
• Institute of medicine. Vaccines for the 21st Century' a Tool for Decisionmaking. National Academy Press, Washington DC, USA, 1–476 (1999).
   Google Scholar
• Shadick NA, Liang MH, Phillips CB, Fossel K, Kuntz KM. The cost-effectiveness of vaccination against LD. Arrb. Intern Med 161,554–561 (2001).
   Google Scholar
• Shapiro ED, Gerber MA. LD. Clin. Infect. Dis. 31,533–542 (2000).
   PubMed Web of Science ®Google Scholar
• Sigal LH. Misconceptions about LD: confusions hiding behind ill-chosen terminology. Ann. Intern. Med 136, 413–419 (2002).
   PubMed Web of Science ®Google Scholar
• LD Vaccine is Taken Off Market. Plishington Post A10, February 27th (2002).
   Google Scholar
• Physician/ Desk Reference. Medical Economics Company, Montvale, NJ, USA, 1592–1596 (2002).
   Google Scholar
• Braun MM, Ellenberg SS. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991–1994.1 Pediati: 131,529-535 (1997).
   Google Scholar
• Lathrop SL, Ball R, Haber P eta] Adverse event reports following vaccination for LD: December 1998 —July 2000. Vaccine 20, 1603–1608 (2002).
   PubMed Web of Science ®Google Scholar
• Gross DM, Forsthuber T, Tary-Lehmann M etal. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281, 703–706 (1998).
   Google Scholar
• ••Laboratory evidence of an autoimrnunetarget for OspA imunity.
   Google Scholar
• Trollmo C, Meyer AL, Steere AC, Hafler DA, Huber BT Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-locL is a partial agonist for outer surface protein A- reactive T-cells. Immunol 166,5286–5291 (2001).
   Web of Science ®Google Scholar
• Steere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J, Nepom GT. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 48,534-540 (2003).
   Google Scholar
• Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T-cell epitope mimicry? Nat. Immunol 2,797–801 (2001).
   Web of Science ®Google Scholar
• •Critical evaluation of OspA autoimmtmity evidence.
   Google Scholar
• Steere AC, Levin RE, Molloy PJ etal. Treatment of Lyme arthritis. Arthritis Rheum 37,878–888 (1994).
   PubMed Web of Science ®Google Scholar
• Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Bonelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl. J. Med. 330,229–234 (1994).
   PubMed Web of Science ®Google Scholar
• Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC. Lack of Bonelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 42,2705–2709 (1999).
   PubMed Web of Science ®Google Scholar
• Akin E, Aversa J, Steere AC. Expression of adhesion molecules in synovia of patients with treatment- resistant lyme arthritis. Infect. Immun. 69,1774–1780 (2001).
   Google Scholar
• Gross DM, Steere AC, Huber BT T-helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol 160,1022–1028 (1998).
   Google Scholar
• Meyer AL, Trollmo C, Crawford F etal. Direct enumeration of Borrelia-reactive CD4 T-cells ex vivo by using MHC class II tetramers. Proc. Natl Acad. Li. USA 97, 11433–11438 (2000).
   Google Scholar
• Rose CD, Fawcett PT, Gibney KM. Arthritis following recombinant outer surface protein A vaccination for LD. Rheumatol 28,2555–2557 (2001).
   Google Scholar
• Croke CL, Munson EL, Lovrich SD etal. Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect. Immun. 68, 658–663 (2000).
   Google Scholar
• FDA LYMErix study to test potential genetic marker for adverse events. The Pink Sheet 63,3, February 5th 2001.
   Google Scholar
• Molloy PJ, Berardi VP, Persing DH, Sigal LH. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A LD vaccination. Clin. Infect. Dis. 31,42–47 (2000).
   PubMed Web of Science ®Google Scholar
• Fawcett PT, Rose CD, Budd SM, Gibney KM. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Clin. Diagn. Lab. Immunol 8,79–84 (2001).
   PubMedGoogle Scholar
• Gomes-Solecki MJ, Wormser GP, Schriefer M et al. Recombinant assay for serodiagnosis of LD regardless of OspA vaccination status. J. Clin. .11/licrobiol 40, 193–197 (2002).
   Google Scholar
• Marks DH, Hosbach P, Koster FT etal. Clinical studies in humans of outer surface protein A (OspA) vaccine for LD. VI International Conference on Lyme Borreliosis Bologna, Italy, June 19–22,1994.
   Google Scholar
• Wormser GP, Nowakowski J, Nadelman RB etal. Efficacy of an OspA vaccine preparation for prevention of LD in New York State. Infection 26,208–212 (1998).
   Google Scholar
• Stover CK, Bansal GP, Hanson MS etal. Protective immunity elicited by recombinant bacille Calmette—Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate LD vaccine. Exp. Med. 178,197-209 (1993).
   Google Scholar
• Langermann S, Palaszynski S, Sadziene A, Stover CK, Koenig S. Systemic and mucosal immunity induced by BCG vector expressing outer- surface protein A of Borrelia burgdorferi Nature 372,552–555 (1994).
   Google Scholar
• Edelman R, Palmer K, Russ KG eta] Safety and immunogenicity of recombinant Bacille Calmette—Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate LD vaccine. Vaccine 17, 904–914 (1999).
   PubMed Web of Science ®Google Scholar
• Eder G, Barrett N, Crowe M, Gerencer M, Livey I, Low-Baselli A. A candidate OspC LD vaccine under clinical investigation. Zentralbl Bakteriol 289, 688–689 (1999).
   Google Scholar
• •Brief overview of second generation LD vaccines with emphasis on OspC Phase I clinical trial.
   Google Scholar
• Guo BP, Brown EL, Dorward DVV, Rosenberg LC, Hook M. Decorin-binding adhesins from Borrelia burgdorferi MoL M'crobiol 30, 711–723 (1998).
   Google Scholar
• Probert WS, Kim JH, Hook M, Johnson BJ. Mapping the ligand-binding region of Borrelia burgdorferifibronectin- binding protein BBK32. Infect. Immun 69, 4129–4133 (2001).
   Google Scholar
• Parveen N, Leong JM. Identification of a candidate glycosaminoglycan-binding adhesin of the LD spirochete Borrelia burgdorferi Md. Illicrobiol 35, 1220–1234 (2000).
   Web of Science ®Google Scholar
• Lam TT Nguyen TP, Montgomery MontgomeryR, Kantor FS, Fikrig Flavell, E. RA. Outer surface proteins E and F of Borrelia burgdorferi, the agent of LD. Infect. Immun. 62, 290–298 (1994).
   PubMed Web of Science ®Google Scholar
• Fikrig E, Feng W Barthold SW Telford SR 3rd, Flavell RA. Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J. Immund 164, 5344–5351 (2000).
   Google Scholar
• Labandeira-Rey M, Baker EA, Skare JT. VraA (BBI16) protein of Borrelia burgdorferi is a surface-exposed antigen with a repetitive motif that confers partial protection against experimental Lyme borreliosis. Infect. Immun. 69, 1409–1419 (2001).
   Google Scholar
• Cassatt DR, Patel NK, Ulbrandt ND, Hanson MS. DbpA but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect. Immun. 66, 5379–5387 (1998).
   PubMed Web of Science ®Google Scholar
• Hagman KE, Yang X, Wilke' SK eta] Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks. Infect. Immun. 68, 4759–4764 (2000).
   PubMed Web of Science ®Google Scholar
• Exner MM, Wu X, Blanco DR, Miller JN, Lovett MA. Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes. Infect. Immun. 68, 2647–2654 (2000).
   Google Scholar
• Hanson MS, Patel NK, Cassatt DR, Ulbrandt ND. Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis. Infect. Immun. 68, 6457–6460 (2000).
   PubMed Web of Science ®Google Scholar
• Luft BJ, Johnson BJ, McGrath B, Dattwyler RJ, Dunn JJ. Chimeric protein vaccine for Lyme borreliosis. VI International Conference on Lyme Borreliosis, Bologna, Italy, June 18–22, 1994.
   Google Scholar
• Wallich R, Siebers A, Jahraus 0, Brenner C, Stehle T, Simon MM. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of LD. Infect. Immun. 69, 2130–2136 (2001).
   Google Scholar
• Pizza M, Scarlato V, Masignani V eta]. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816–1820 (2000).
   Google Scholar
• Wizemann TM, Heinrichs JH, Adamou JE et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun 69, 1593–1598 (2001).
   PubMed Web of Science ®Google Scholar
• Fraser CM, Casjens S, Huang WM eta] Genomic sequence of a LD spirochaete, Borrelia burgdorferi. Nature 390, 580–586 (1997).
   PubMed Web of Science ®Google Scholar
• Casjens S, Palmer N, van Vugt R eta]. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the LD spirochete Borrelia burgdorferi. Md. M'crobiol. 35, 490–516 (2000).
   Google Scholar
• Das S, Barthold SW Giles SS, Montgomery Montgomery R, Telford SR 3rd, Fikrig E. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J. Gin. Invest. 99, 987–995 (1997).
   Google Scholar
• Fikrig E, Chen M, Barthold SW eta]. Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Nlicrobiol. 31, 281–290 (1999).
   Google Scholar
• Patel NK, Alsruhe JP, Cassatt DR, Bachy CM, Hanson MS, Pizer ES. Immunohistochemical analysis of lipoprotein antigens expressed by Borrelia burgorferi during persistent infection of mice provides insights into the pathogenesis of LD. Mod. Pathol 13, 171A (2000).
   Google Scholar
• Ohnishi J, Piesman J, de Silva AM. Antigenic and genetic heterogeneity of Borrelia burgdorferipopulations transmitted by ticks. Proc. Natl Acad. Li. USA 98, 670–675 (2001). Thorough documentaion of Bb antigenic heterogeneity during, and just after tick transmission.
   Google Scholar
• Fingerle V, Laux H, Munderloh UG, Schulte-Spechtel U, Wilske B. Differential expression of outer surface proteins A and C by individual Borrelia burgdorferi in different genospecies. Med. Mcrobiol Immunol a3erli 189, 59–66 (2000).
   Google Scholar
• Barthold SW Fikrig E, Bockenstedt BockenstedtL, Persing DH. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect. Immun. 63, 2255–2261 (1995).
   PubMed Web of Science ®Google Scholar
• Gilmore RD Jr, Kappel KJ, Dolan MC, Burkot TR, Johnson BJ. Outer surface protein C (OspC) but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect. Immun. 64, 2234–2239 (1996).
   Google Scholar
• Feng S, Hodzic E, Barthold SW Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein. Infect. Immun. 68, 4169–4173 (2000).
   Google Scholar
• Barthold SW Feng S, Bockenstedt BockenstedtL, Fikrig Feen, E. K. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Gin. Infect. Dir. 25\(Suppl. 1), S9—S17 (1997).
   Google Scholar
• Lahdenne P, Porcella SF, Hagman KE et al. Molecular characterization of a 6.6-kilodalton Borrelia btugdorferi outer membrane-associated lipoprotein (1p6.6) which appears to be downregulated during mammalian infection. Infect. Immun. 65, 412–421 (1997).
   Google Scholar
• Liang FT, Jacobs MB, Philipp MT C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi. Infect. Immun. 69, 1337–1343 (2001).
   PubMed Web of Science ®Google Scholar
• Fikrig E, Barthold SW Sun W Feng W Telford SR 3rd, Flavell RA. Borrelia burgdorferiP35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity6, 531–539 (1997).
   Google Scholar
• Das S, Shraga D, Gannon C eta] Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue. Res. Alicrobiol. 147, 739–751 (1996).
   Google Scholar
• Feng S, Barthold SW Telford SR 3rd, Fikrig E. P55, an immunogenic but nonprotective 55-kilodalton Bortdia burgdorferi protein in murine LD. Infect. Immun. 64, 363–365 (1996).
   Google Scholar
• Wilke' SK, Ramachandra RN, Bergman DK, Burkot TR, Piesman J. Infestation with pathogen-free nymphs of the tick Ixodes scapularis induces host resistance to transmission of Bondia burgdmferi by ticks. Infect. Immun. 65, 335–338 (1997).
   PubMed Web of Science ®Google Scholar
• Nazario S, Das S, de Silva AM eta]. Prevention of Borrelia burgdorferi transmission in guinea-pigs by tick immunity. Am. J. Trop. Med. hjg 58,780–785 (1998).
   Google Scholar
• Das S, Deponte K, Marcantonio NL eta]. Granulocytic ehrlichiosis in tick-immune guinea-pigs. Infect. Immun. 66, 1803–1805 (1998).
   PubMed Web of Science ®Google Scholar